🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

France's Imerys in U.S. deal to resolve talc-related liabilities

Published 05/15/2020, 02:31 AM
Updated 05/15/2020, 02:35 AM
© Reuters.
IMTP
-
JNJ
-

PARIS (Reuters) - French manufacturing and minerals group Imerys SA (PA:IMTP), whose North America talc unit filed for bankruptcy after being drawn into cancer lawsuits, said on Friday it had reached an agreement to resolve those talc-related liabilities.

"Today’s announcement marks an important step toward a permanent resolution of historic talc-related liabilities," said CEO Alessandro Dazza.

Imerys said the group's contribution to the plan to resolve the issue would consist of a minimum cash payment of $75 million, and a further amount of up to $102.5 million subject to a reduction mechanism proportionate to the sale price for the assets of its North American talc subsidiaries.

Imerys said the agreement had been filed in the United States Bankruptcy Court in the District of Delaware and was expected to lead to a sale of the assets of its North America talc subsidiaries.

Imerys' North America talc division filed for bankruptcy after being drawn into cancer lawsuits connected to Johnson & Johnson's (N:JNJ) baby powder.

Imerys and J&J have repeatedly denied the allegations about talc, saying numerous studies and tests by regulators worldwide have shown their talc to be safe.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.